Interestingly, high Arg1 expression has been associated with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) in humans, and both of these diseases are commonly associated with AHN in patients with systemic mastocytosis (38–40). Here, ARG1 is linked to myelodysplastic syndrome.